Funder
National Natural Science Foundation of China
Natural Science Foundation of Shandong Province
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference207 articles.
1. Nanomedicines accessible in the market for clinical interventions;Gadekar;J Contr Release,2021
2. Cancer nanomedicine: progress, challenges and opportunities;Shi;Nat Rev Cancer,2017
3. Progress, challenges, and future of nanomedicine;Zhang;Nano Today,2020
4. FDA. Considering whether an FDA-regulated product involves the application of nanotechnology. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considering-whether-fda-regulated-product-involves-application-nanotechnology.
5. Clinical cancer nanomedicine;Wolfram;Nano Today,2019
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献